Press Release: Numinus Wellness research facility licensed by Health Canada to supply psilocybin mushrooms
Cannabis Law Report
JANUARY 31, 2022
The SAP is a federal program that allows healthcare professionals to apply for access to non-marketed medications that have not yet been approved for sale, when such medications show clinical evidence of safety and efficacy and are intended to treat patients with a severe or life-threatening illness.
Let's personalize your content